Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-16 Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc Exercise or conversion · Restricted Stock Unit −15,062 66,997
2024-01-16 O'NEIL PATRICK R. EVP CLO & General Counsel Exercise or conversion +20,641 60,996
2024-01-16 O'NEIL PATRICK R. EVP CLO & General Counsel Exercise or conversion · Restricted Stock Unit −20,641 47,414
2024-01-16 Birchler Brian EVP, Corp and Development Ops Exercise or conversion +12,080 49,079
2024-01-16 Birchler Brian EVP, Corp and Development Ops Exercise or conversion · Restricted Stock Unit −12,080 46,248
2024-01-16 Swayze Eric EVP Research Exercise or conversion +17,069 49,585
2024-01-16 Swayze Eric EVP Research Exercise or conversion +21 94
2024-01-16 Swayze Eric EVP Research Exercise or conversion · Restricted Stock Unit −17,069 46,728
2024-01-16 Swayze Eric EVP Research Exercise or conversion · Restricted Stock Unit −21 551
2024-01-16 Schneider Eugene EVP, Chf Clinical Develop Ofcr Exercise or conversion +15,162 53,332
2024-01-16 Schneider Eugene EVP, Chf Clinical Develop Ofcr Exercise or conversion · Restricted Stock Unit −15,162 45,308
2024-01-16 Monia Brett P Chief Executive Officer Exercise or conversion +68,084 186,195
2024-01-16 Monia Brett P Chief Executive Officer Exercise or conversion · Restricted Stock Unit −68,084 $10.00 $681K 196,212
2024-01-16 HOUGEN ELIZABETH L EVP, Finance & CFO Exercise or conversion +22,487 99,573
2024-01-16 HOUGEN ELIZABETH L EVP, Finance & CFO Exercise or conversion · Restricted Stock Unit −22,487 62,056
2024-01-16 Geary Richard S EVP, Chief Development Officer Exercise or conversion +19,852 92,813
2024-01-16 Geary Richard S EVP, Chief Development Officer Exercise or conversion · Restricted Stock Unit −19,852 46,625
2024-01-16 BENNETT C FRANK EVP, Chief Scientific Officer Exercise or conversion +18,314 84,068
2024-01-16 BENNETT C FRANK EVP, Chief Scientific Officer Exercise or conversion · Restricted Stock Unit −18,314 23,500
2024-01-16 Baroldi Joseph EVP, Chief Business Officer Exercise or conversion +3,688 14,259

Page 42 of 44 · 873 trades